secwatch / observer
8-K filed December 19, 2023, 6:59 PM ET ticker VTVT CIK 0001641489
regulatory confidence high sentiment negative materiality 0.80

vTv Therapeutics Inc. (VTVT): Nasdaq/NYSE listing notice — vTv Therapeutics receives Nasdaq delisting notice for MVLS non-compliance

vTv Therapeutics Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

vTv Therapeutics Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

Exchange
nasdaq
Notice
noncompliance notice
Deficiency
market value
Rules
5550(b)(2), 5810(c)(3)(C)
Exact text from the filing
December 13, 2023, vTv Therapeutics Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirement of Nasdaq Listing Rule 5550(b)(2) because the Company's listed securities have been below the required market value of listed securities (MVLS) of $35 million for the last 30 consecutive business days. In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has 180 calendar days, or until June 10, 2024, to regain compliance with Nasdaq Listing Rule 5550(b)(2). Compliance can be achieved without f
View on SEC.gov

Browse all listing & compliance notices →

vTv Therapeutics Inc. filing history →

Source: SEC EDGAR
accession 0001641489-23-000085
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.